Welcome to Newfield Therapeutics Corporation

About Us


Scientific and Business Affiliations

Newfield Therapeutics Corporation in conjunction with its academic partner, the Institute of Molecular Biosciences of Karl Franzens University in Graz, Austria and its corporate partner, Sanochemia Pharmazeutika AG, based in Vienna and having research laboratories and manufacturing facilities in Neufeld, Austria, is engaged in the development of novel diagnostic and therapeutic oncological approaches. 


Bladder Cancer Diagnosis and Therapy

Furthest along is VIDON , its trademarked  bladder cancer diagnostic with phase IIb clinical studies having been completed, and indications of therapeutic effects having been shown in vitro. 


Anti-Cancer Peptides

International Patents for Newfield’s anti cancer peptides have recently been issued and apply to a broad range of solid tumors, exploiting the interaction between human lactoferricin derivatives and phosphatidylserine, expressed on the outside of cancerous cells. In order to advance from the preclinical stage to clinical studies Newfield is entertaining academic and corporate partnerships.  

Contact Us


Newfield Therapeutics Corporation

9201 University City Blvd, Charlotte, NC 28223, USA

(704) 953-5597

Drop us a line!

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.